The Lies and Facts Behind Vaccine Opposition! Why Has Risk–Benefit Perception Deteriorated?

🌍 Taking Stock of 50 Years: 154 Million Lives and 10.2 Billion Healthy Years

The year 1974 marked a turning point in global health history. Launched by the World Health Organization (WHO), the “Expanded Programme on Immunization (EPI)”aimed to protect children throughout the world, not just in a few countries. Many infectious diseases were still claiming millions of children's lives then: measles, diphtheria, tetanus, pertussis and polio were among the best known.

Where Have We Arrived After 50 Years? A comprehensive 2024 analysis published in The Lancetprovides striking answers. Modeling estimates suggest that EPI has so far saved 154 million lives. This is more than a number; behind it are families who did not lose their children, individuals who grew up to contribute to society, and futures filled with hope rather than disease.

Looking more closely, among those saved were 146 million children under 5, 101 million of them infants under 1 year. The most vulnerable groups therefore benefited the most, clearly showing that vaccines are a direct investment in the future.

Researchers calculated that each death prevented yielded an average of 66 years of full health , amounting to a total of 10.2 billion years of healthy life—an extraordinary gain. Vaccines have therefore not only reduced mortality but also added quality, productive years to millions of lives.

These gains are particularly evident in the dramatic decline in infant mortality . Vaccines account for approximately 40% of the global reduction in infant mortality, rising in Africa to 52% . This shows how a simple health intervention can transform an entire continent's demographic future.

EPI's success teaches us that vaccine access is an issue of equity that changes the destinies of societies as well as individuals. An infant's chance of survival should not depend on the geographical or economic boundaries of the country of birth. Universal immunization is our strongest tool for reducing this inequality.

Public Trust: Science and Vaccine Perception

Even the most effective medical solutions cannot succeed without public trust. Here, Wellcome Trustpublished in 2019 its large-scale Wellcome Global Monitor report, the first global study assessing public views of science and vaccines. Interviews with more than 140,000 people in 140 countriesmapped trust in science.

The findings were surprising. Worldwide, 79% of people believed vaccines were safe. But this proportion varied by region. 95% in South Asia, 92% in East Africa were high rates, whereas figures fell to 59% in Western Europe, 50% in Eastern Europe . This pattern tells us something important: Vaccine confidence falls in societies that have forgotten the disease.

In Africa, for example, many mothers are willing to walk kilometers in scorching heat to obtain measles vaccination for their children, because stories of children lost to measles remain vivid. In parts of Europe, however, measles is rarely seen, and society has forgotten why vaccines are necessary. This is a striking example of what scientists call “disease amnesia.”

Trust highlights not only vaccines but also the role of healthcare professionals . Worldwide, 84% of people trust advice from doctors and nurses. When the same advice comes from governments, trust falls to 76% . The white coattherefore remains the most trusted authority in many societies.

The report also shows strong interest in science: Approximately 62% of people want to learn more about science, rising in low-income countries to 72% . As access to information becomes harder, curiosity and the desire to learn increase.

The future of vaccines is therefore shaped not only in laboratories but also in the hearts of societies. Vaccine acceptance is high where trust in science is high. When trust declines, however, misinformation gains a foothold. Vaccine communication thus means more than sharing data; it requires building an “architecture of trust” that reinforces public confidence.

🧪 An Extreme Case: 217 Doses of COVID-19 Vaccine

In 2024, The Lancet Infectious Diseases an unusual case report published in the journal attracted worldwide attention. A 62-year-old man living in Magdeburg, Germany, had received 217 doses of COVID-19 vaccine over 29 months . He experienced no serious adverse effects during this period, and routine health examinations found no abnormalities.

Why so many vaccinations? According to the researchers, the patient's immune system was weakened by an autoimmune disease. The initial doses were given under healthcare supervision, but he later continued vaccination on his own initiative. More than 130 doses were officially documented, making this a unique scientific example of “hypervaccination.”

Researchers examined blood samples to assess his immune response. The findings were interesting: Antibody levels were significantly higher than in people who had received only a few doses. In addition, neutralizing capacity against the Omicron variant was, compared with controls, 5 to 11 times stronger . CD8+ T-cell responses were also higher than expected. Immunologically, the body therefore appeared to respond strongly rather than adversely to this excessive dosing.

What does this mean? First, it must be emphasized that: This is only a single case. Although the findings support the general safety of vaccines, they do not mean that “everyone can receive 200 doses.” Clinical trials and randomized controlled studies remain at the top of the evidence pyramid. Individual examples can only generate ideas.

Another aspect of this story is its public message. Anti-vaccine rhetoric often focuses on rare adverse effects and obscures the bigger picture. This man's story is significant because it demonstrates that no serious safety signal appeared even with repeated high-dose vaccination . It reminds us again how well vaccines can be tolerated.

Nevertheless, such a practice is absolutely not recommended medically or ethically. Vaccination programs aim to protect public health safely and in balance, rather than enable individual experiments. Although this case offers a striking anecdote about vaccine safety, the real lesson is: Science draws strength from rigorous, systematic studies rather than extreme examples.

⚖️ Implications and Looking Ahead

To avoid getting lost in vaccine debates, we need only examine the available data. History has taught us clearly that: Vaccines are safe and save lives. The eradication of smallpox, near-elimination of polio worldwide and dramatic decline in measles deaths are the strongest evidence.

The COVID-19 pandemicreminded us again. In the first year alone, approximately 20 million deaths were prevented. If every country had vaccinated at least 40% of its population by the end of 2021, as the WHO specified, an additional 600,000 lives could have been saved. These figures show how critical vaccine inequity is.

Meanwhile, societies' memory of disease is fading. As generations who have never seen measles or pertussis forget how deadly these diseases can be, the need for vaccination comes into question. Remembering an African mother walking for hours to obtain a vaccine for her child shows how misleading this amnesia can be.

We also have next-generation technologies. mRNA vaccinesenabled an unprecedentedly rapid pandemic response. This technology is our strongest asset against future pathogens. Rather than dismiss or abandon it, we should develop it and expand access.

Vaccine policy in the coming years should therefore address social, economic and cultural dimensions alongside biology. A vaccine is more than an injection; it is a matter of equity, trust and scientific common sense.

🌟 Final Thoughts

Today, strong evidence exists at both individual level (clinical trials, case reports) and population level (50-year global analyses, trust surveys). Vaccines save millions of lives, gain billions of healthy years and shape societies' futures.

This is especially clear in vulnerable groups such as oncology patients: A vaccine is more than prevention; for someone seeking a chance at treatment, it becomes an invisible shield helping sustain life.

To prepare for future outbreaks, respond rapidly to new pathogens and maintain public trust, we must preserve common sense about risk and benefit. Societies that listen to science are protected from fear as well as disease. Vaccines are the clearest symbol of that trust and science.

📚 References

• Rubin EJ. Risk and Benefit: Common Sense and the Value of Vaccines. The New England Journal of Medicine. September 24, 2025. NEJM
• Shattock AJ, Johnson HC, Sim SY, Carter A, Lambach P, Hutubessy RC, et al. Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization. The Lancet. May 2, 2024. The Lancet
• Wellcome Trust. Wellcome Global Monitor 2018. Report published: 2019. Report page
• Schober K, Kocher K, et al. (Germany, Magdeburg case). Immunological and clinical observations in an individual receiving 217 SARS-CoV-2 vaccine doses. The Lancet Infectious Diseases. 2024. Lancet Infect Dis